Jaguar Health announced it has engaged B2i Digital to execute an innovative digital investor engagement and awareness program. B2i will harness its investor platform and data-driven digital marketing expertise to highlight Jaguar’s novel pipeline of prescription drugs sustainably derived from rainforest plants.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on JAGX:
- Jaguar Health’s Napo completes last patient visit for Phase 3 OnTarget trial
- Jaguar Health announces results of survey of neurologists, patients, caregivers
- Jaguar Health reports Q2 EPS (42c) vs. (12c) last year
- Jaguar Health’s Napo submits funding application to BARDA for NP-300
- Jaguar Health’s Napo says FDA activates IND application for crofelemer